Clinical Trials Browser

Phase 2 × neratinib × Tumor-Agnostic × Clear all

NCT05933395 2026-01-20

GERTRUDE

Phase 2 Recruiting

Neoplasm Metastasis

NCT06083662 2025-03-18

Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers

Phase 2 Completed

Neoplasm Metastasis